Frank Akwaa

Frank Akwaa, M.D. serves as an Associate Professor in the Department of Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He practices clinically at the Wilmot Cancer Center and Strong Memorial Hospital in Rochester, NY, specializing in non-malignant hematology with expertise in coagulation disorders, hemoglobinopathies, and sickle cell disease management.

Education:

• MD, University of Rochester School of Medicine/Dentistry (2007)
• Residency & Internship in Internal Medicine, Johns Hopkins Bayview Medical Center (2007-2010)
• Fellowship in Hematology & Oncology, University of Rochester Medical Center (2010-2013)

Dr. Akwaa's research centers on optimizing care for complex blood disorders, particularly venous thromboembolism management, bleeding complications in anticoagulated patients, and transition protocols for sickle cell disease. His clinical approach emphasizes collaborative decision-making and long-term patient relationships, evidenced by consistently high patient satisfaction scores across communication, empathy, and treatment explanations.

Analysis of his 2004-2016 publications reveals a clinical research trajectory focused on practical hematology challenges, with dominant themes in anticoagulation therapy safety and sickle cell transition care. While primarily clinical, his work spans molecular biology (2004) and neurology (2005), demonstrating interdisciplinary versatility within hematology's broader ecosystem.

Scientific Awards:

• Wilmot Cancer Research Fellowship (2013-2016)
• ASCO Resident Ravel Award (2010)
• University of Rochester Summer Research Fellowship
• Jonas E. Salk Scholarship Award
• Phi Beta Kappa & Sigma Xi Honor Societies
• MARC Scholarship & Eugene Lang Research Award
• Stephen Bucholz Award for Biological Sciences

Dr. Akwaa mentors hematology fellows as part of his clinical duties, though formal graduate student advisement isn't documented. His Wilmot Cancer Research Fellowship (2013-2016) represents significant prior research support, while current clinical operations are integrated within UR Medicine's Accountable Health Partners network. Patient testimonials consistently highlight his thorough chart review, compassionate communication, and expertise in complex non-malignant hematology cases.

He operates within the comprehensive hematology division at Wilmot Cancer Center, collaborating with multidisciplinary teams to manage conditions ranging from thrombocytopenias to rare porphyrias, with strong emphasis on personalized treatment planning for life-altering blood disorders.